DDO-5936 is a potent and specific Hsp90-Cdc37 PPI inhibitor. DDO-5936 can be used for the research of colorectal cancer.
体外研究
DDO-5936 is a Hsp90-Cdc37 PPI inhibitor with potency and specificity through binding to a critical site on Hsp90 involving Glu47.
体内研究
DDO-5936 (0~80 mg/kg; p.o.) shows effect at the high dose group.
DDO-5936 is well tolerated for the absence of serious weight loss. DDO-5936 high dose groups show that tumor cells in the xenografts decreased significantly. DDO-5936 shows limited oral efficiency.
Animal Model:
Mice
Dosage:
0~80 mg/kg
Administration:
P.o.
Result:
Showed a moderate effect at the high dose group.
分子式
C25H29N5O4S
分子量
495.59
CAS号
2355377-13-6
运输条件
Room temperature in continental US; may vary elsewhere.